1-24 of 43 Books

Principles and Techniques of Human Research and Therapeutics: Selected Topics
By Francis Gilbert McMahon

New targets in inflammation
By Jack H. Botting,John R. Vane,N. Bazan,Jack H Botting

Selective COX-2 inhibitors
By John R. Vane,Jack H. Botting

Inflammation in the Pathogenesis of Chronic Diseases
By Randall E. Harris
Effect of a non-steroidal, anti-inflammatory drug (Indocin) on selected parameters of muscular function following concentric and eccentric work
Effect of a non-steroidal, anti-inflammatory drug (Indocin) on selected parameters of muscular function following concentric and eccentric work
By Maria Eugenia Vejarano

COX-2 blockade in cancer prevention and therapy
By Randall E. Harris

Non-steroidal anti-inflammatory drugs, basis for variability in response
By Peter Brooks,Day, Richard

Nonsteroidal Anti-Inflammatory Drugs
By Alan J. Lewis
Safety, Efficacy and Mechanisms
Safety, Efficacy and Mechanisms
By F.D.R. Hobbs

COX-2 Inhibitor Research
By Maynard J. Howardell

Clinical Significance And Potential Of Selective Cox-2 Inhibitors
By John R. Vane
Risk and responsibility
Risk and responsibility
By United States. Congress. House. Committee on Government Reform

Safety and efficacy of non-prescription (OTC) analgesics and NSAIDs
By K. D. Rainsford
Piroxicam
Piroxicam
By Congress of Rheumatology (15th 1981 Paris, France)

Etodolac - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
By ICON Health Publications

Trends in Cox-2 Inhibitor Research
By Maynard J. Howardell

IARC Handbooks of Cancer Prevention, Volume 1
By IARC Working Group on the Evaluation of Cancer Preventive Agents

Improved non-steroid anti-flammatory drugs COX-2 enzyme inhibitors
By John R. Vane

Improved non-steroid anti-inflammatory drugs
By William Harvey Conference (1995 London, England)
Bioequivalence studies of ketoprofen
Bioequivalence studies of ketoprofen
By Kris Edward Holt
The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis
The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis
By Andreas Maetzel
Economic assessment
Economic assessment
By Andreas Maetzel